The concordance between decreased SOD activity and NOx concentration, combined with the genotypes of SOD3 Ala/Ala and/or eNOS Glu/Glu in hypertensive patients, may be useful in directing the antioxidant therapy of hypertension. This evidence concerns the gene SOD1 and hypertensive disorder.